Cargando…

Interleukin-8 Is Activated in Patients with Chronic Liver Diseases and Associated with Hepatic Macrophage Accumulation in Human Liver Fibrosis

BACKGROUND: Interleukin-8 (IL-8, CXCL8) is a potent chemoattractant for neutrophils and contributes to acute liver inflammation. Much less is known about IL-8 in chronic liver diseases (CLD), but elevated levels were reported from alcoholic and hepatitis C-related CLD. We investigated the regulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmermann, Henning W., Seidler, Sebastian, Gassler, Nikolaus, Nattermann, Jacob, Luedde, Tom, Trautwein, Christian, Tacke, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3120868/ https://www.ncbi.nlm.nih.gov/pubmed/21731723 http://dx.doi.org/10.1371/journal.pone.0021381

Ejemplares similares

Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14(+)CD16(+) Monocytes to Inflammation and Human Liver Fibrosis
por: Zimmermann, Henning W., et al.
Publicado: (2010)

Pharmacological Inhibition of the Chemokine CXCL16 Diminishes Liver Macrophage Infiltration and Steatohepatitis in Chronic Hepatic Injury
por: Wehr, Alexander, et al.
Publicado: (2014)

Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytes
por: Seidler, Sebastian, et al.
Publicado: (2012)

Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
por: Liedtke, Christian, et al.
Publicado: (2022)

Functional Role of Monocytes and Macrophages for the Inflammatory Response in Acute Liver Injury
por: Zimmermann, Henning W., et al.
Publicado: (2012)

U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis
por: Benz, Fabian, et al.
Publicado: (2013)

Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion
por: Bartneck, Matthias, et al.
Publicado: (2020)

Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
por: Liedtke, Christian, et al.
Publicado: (2013)

Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults
por: Seidler, Sebastian, et al.
Publicado: (2010)

Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
por: Hao, Fengjie, et al.
Publicado: (2017)

Micro-RNA Profiling in Human Serum Reveals Compartment-Specific Roles of miR-571 and miR-652 in Liver Cirrhosis
por: Roderburg, Christoph, et al.
Publicado: (2012)

Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
por: Puengel, Tobias, et al.
Publicado: (2017)

Interleukin‐18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis
por: Knorr, Jana, et al.
Publicado: (2023)

An NF-kappaB- and IKK-Independent Function of NEMO Prevents Hepatocarcinogenesis by Suppressing Compensatory Liver Regeneration
por: Koppe, Christiane, et al.
Publicado: (2019)

The CCR2(+) Macrophage Subset Promotes Pathogenic Angiogenesis for Tumor Vascularization in Fibrotic Livers
por: Bartneck, Matthias, et al.
Publicado: (2018)

The Janus-like Face of IL-4Rα in Macrophages during Liver Fibrosis
por: Ritz, Thomas, et al.
Publicado: (2018)

A General Overview on Non-coding RNA-Based Diagnostic and Therapeutic Approaches for Liver Diseases
por: Roy, Sanchari, et al.
Publicado: (2018)

Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression
por: Sonntag, Roland, et al.
Publicado: (2021)

Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2021)

Circulating Levels of Osteopontin Predict Patients’ Outcome after Resection of Colorectal Liver Metastases
por: Loosen, Sven H., et al.
Publicado: (2018)

The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity
por: Schueller, Florian, et al.
Publicado: (2018)

Improved Recovery from Liver Fibrosis by Crenolanib
por: Reichert, Doreen, et al.
Publicado: (2021)

Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo
por: Tacke, Frank
Publicado: (2012)

Circulating MicroRNA-223 Serum Levels Do Not Predict Sepsis or Survival in Patients with Critical Illness
por: Benz, Fabian, et al.
Publicado: (2015)

The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation
por: Beyer, Dustin, et al.
Publicado: (2022)

Liver fibrosis and CD206(+) macrophage accumulation are suppressed by anti-GM-CSF therapy
por: Tan-Garcia, Alfonso, et al.
Publicado: (2019)

Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies
por: Ju, Cynthia, et al.
Publicado: (2016)

Hepatocytes reprogram liver macrophages involving control of TGF-β activation, influencing liver regeneration and injury
por: Wolf, Stephanie D., et al.
Publicado: (2023)

Liver Macrophages: Old Dogmas and New Insights
por: Guillot, Adrien, et al.
Publicado: (2019)

Hepatic Macrophage Abundance and Phenotype in Aging and Liver Iron Accumulation
por: Bloomer, Steven A.
Publicado: (2022)

Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)

Modulation of Liver Inflammation and Fibrosis by Interleukin-37
por: Mountford, Steffeni, et al.
Publicado: (2021)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

IL-6 and IL-8 Serum Levels Predict Tumor Response and Overall Survival after TACE for Primary and Secondary Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2018)

Endoglin in human liver disease and murine models of liver fibrosis—A protective factor against liver fibrosis
por: Alsamman, Muhammad, et al.
Publicado: (2017)

Interleukins in chronic liver disease: lessons learned from experimental mouse models
por: Hammerich, Linda, et al.
Publicado: (2014)

The versatility of macrophage heterogeneity in liver fibrosis
por: Gao, Chun-Chen, et al.
Publicado: (2022)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
por: Li, Hai, et al.
Publicado: (2016)

Interleukin-10 Attenuates Liver Fibrosis Exacerbated by Thermoneutrality
por: Nga, Ha Thi, et al.
Publicado: (2021)

Sarcopenia Is a Negative Prognostic Factor in Patients Undergoing Transarterial Chemoembolization (TACE) for Hepatic Malignancies
por: Loosen, Sven H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ue1m0qjhdljo1tpoo1sqsr1io9